We examined the replicative properties of a series of sequential isolates and biological clones of human immunodeficiency virus type 1 (HIV-1) obtained from an individual who progressed from seroconversion to AIDS in approximately 5 years. HIV-1 isolated soon after seroconversion replicated slowly and to low levels in cultures of peripheral blood mononuclear cells; however, subsequent isolates obtained during asymptomatic infection showed a marked increase in replication kinetics. This was examined in more detail by using a panel of 35 biological clones of HIV-1 generated from sequential patient peripheral blood mononuclear cell samples. Each clone was evaluated for replication in primary macrophages and CD4+ T lymphocytes and for the ability to induce syncytium formation in MT-2 cell cultures. Consistent with earlier observations, we found that all of the clones isolated just after seroconversion were slowly replicating and non-syncytium inducing (NSI). However, NSI variants with increased replication kinetics in macrophages were identified soon thereafter. These variants preceded the appearance of NSI and syncytium-inducing variants, with rapid replication in both macrophages and CD4+ T lymphocytes. To determine whether changes in the rate of replication could be traced to the early stages of the virus life cycle, PCR assays were used to evaluate entry and reverse transcription of selected biological clones in macrophages and CD4+ T lymphocytes. We found there was no inherent block to entry or reverse transcription for the slowly replicating variants; however, this does not preclude the possibility that small differences in the rate of entry may account for larger differences in the replication kinetics over many cycles. Overall, our results demonstrate that rapidly replicating variants of HIV-1 emerge during the asymptomatic period in a patient who subsequently progressed clinically, suggesting that these variants may play an important role in HlV-1 pathogenesis.
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Isolates of human immunodeficiency virus type 1 (HIV-1) can be distinguished by differences in replication rate, cell tropism, and cytopathic effects in vitro (3). In longitudinal studies, changes in the biological properties of sequential isolates have been associated with clinical progression and the onset of AIDS. Virus isolated from individuals shortly after seroconversion and during asymptomatic infection is predominantly macrophage tropic and non-syncytium inducing (NSI) in vitro (6, 29, 34, 35, 38, 39, 44) . The emergence of T-cellline-tropic, syncytium-inducing (SI) variants occur in about 50% of symptomatic patients and has been associated with rapid CD4+ T-cell decline and the development of AIDS (38) (39) (40) . HIV-1 isolates from asymptomatic individuals also replicate more slowly in culture than do isolates from patients with AIDS (1, 12, 39) , suggesting that selection for variants with increased growth potential may occur during the course of infection. It is possible that more rapidly replicating variants contribute to the development of immune dysfunction, or alternatively, these viruses may only emerge later as a result of immune system compromise and declining CD4+ T cells.
In vivo, HIV-1 is primarily targeted to CD4+ T lymphocytes and CD4+ cells of monocyte/macrophage lineage. Determinants which govern cell tropism have been mapped predominantly to the env gene (4, 18, 20, 24, 36, 41, 42) . Exchanging regions of env, notably the V3 region of the surface glycoprotein gpl20, between viruses with distinct tropisms has been (212) . Electronic mail address: Ho@phri.nyu.edu.
shown to influence entry into susceptible target cells, including macrophages (24) and CD4+ T cells (2, 5, 19) . In addition, several regions of gpl20, including sequences within the V2 (15) and V3 (8, 14) loops, contain known determinants of SI capacity. The env gene of HIV-1 is subject to a high degree of genetic diversity (23, 37) , and it is reasonable to assume that immune and other selection pressures exerted on this region during infection may drive the evolution of variants with expanded tropism and increased cytopathicity. It is not clear, however, whether these changes also affect the efficiency of viral entry into susceptible target cells and contribute to increased rates of viral replication.
In this study, we examined in detail the phenotypic properties of a large series of sequential isolates and biological clones of HIV-1 derived from a single individual throughout the course of infection. We observed a progressive increase in the replication kinetics of sequential isolates in peripheral blood mononuclear cells (PBMC), with the most dramatic changes occurring during the period when this patient was clinically asymptomatic, with normal CD4+ T-cell levels. Predominantly slowly replicating, NSI viruses were isolated shortly after seroconversion; however, NSI variants with increased replication kinetics in macrophages were identified soon thereafter. These variants preceded the appearance of both NSI and SI clones with increased replication in macrophages and primary CD4+ T lymphocytes. We did not detect significant differences in the rate of entry and reverse transcription among biological clones with distinct replicative capacities, although this does not rule out the possibility that small differences in the efficiency viral 
MATERIALS AND METHODS
Generation of primary isolates and biological clones. Patient B was selected from a large cohort of homosexual men evaluated at the New York Blood Center as part of a prospective AIDS study (6) . His clinical course was marked by a very rapid decline in CD4+ T cells which occurred approximately 3 years after seroconversion for HIV-1 (Fig. 1) . Samples of plasma and PBMC were collected at regular intervals throughout infection and stored in liquid nitrogen.
Sequential isolates of HIV-1 were obtained by a quantitative coculture method as previously described (16) . Briefly, cryopreserved patient PBMC were thawed and the cells were serially diluted fourfold (from 106 cells down to approximately 103) in replicates of 4 to 10. Phytohemagglutinin (PHA)-stimulated normal donor PBMC (2 x 106) were added in 1.5 ml of RPMI 1640 medium supplemented with 10% heatinactivated fetal calf serum, penicillin (100 U/ml), streptomycin (100 ,ug/ml), and interleukin-2 (10 U/ml). The cocultures were incubated for 24 h at 37°C and washed three times with fresh medium. Samples of the culture supernatants were assayed for HIV-1 p24 antigen on days 7, 14, and 21, using a commercial enzyme-linked immunosorbent assay (ELISA; Abbott Laboratories, North Chicago, Ill.). A culture was considered positive if the p24 value was above a cutoff value of 30 pg/ml. Supernatant from the first well of each titration was pooled from replicate wells, and the virus was propagated by a single short-term passage (5 to 7 days) in PBMC. This virus was designated P1. Biological clones were generated by short-term propagation of the virus present in the last positive well of each titration (7) . In general, 4 to 10 biological clones were obtained from each PBMC sample. The P1 isolates and biological clones were titrated on normal donor PBMC to determine the infectious titer, and the 50% tissue culture infective dose (TCID50) was calculated by the method of Reed and Muench (10 Phenotype characterization. The P1 isolates and biological clones were first assessed for infectivity and replication in either PBMC, macrophages, or CD4+ T lymphocytes. The cells were inoculated with a standardized input of each virus, incubated for 24 h at 37°C, and washed twice with fresh medium. Samples of culture supernatants were taken immediately after washing (day 0) and on designated days thereafter and assayed for the presence of HIV-1 p24 antigen by ELISA. To evaluate syncytium formation, MT-2 cells (106) were inoculated with each virus. Syncytium formation was evaluated in the cultures on days 7, 10, and 14 by standard light microscopy.
Samples of the culture supernatants were tested in parallel for HIV-1 p24 antigen. All cultures that were positive for syncytium formation also had p24 values of 1,000 pg/ml or greater. Conversely, all cultures that lacked syncytium formation were negative for p24 antigen. We have previously noted this correlation (6) , suggesting that MT-2 cell tropism and syncytium formation may be linked properties. Cultures that were positive for both syncytium formation and p24 antigen were designated SI, whereas cultures negative for syncytium formation and p24 were designated NSI. 8 .0], 0.5% sodium dodecyl sulfate, 100 jig of proteinase K per ml, 20 jig of RNase per ml). To prepare DNA from macrophage cultures, the adherent cells were washed directly in the plates by aspiration and lysed with 500 ml of DNA lysis buffer. DNA was recovered from cell lysates by sequential extraction with phenol-chloroform-isoamyl alcohol (25:24:1) and chloroform followed by ethanol precipitation, Fig. 3 .
b Evaluated in MT-2 cell cultures on days 7 and 10 after infection.
further evaluation on the basis of differences in their replication kinetics in macrophages and CD4+ T lymphocytes (Fig.  3) . Clones 2-5 and 2-6 replicated slowly and to low levels in both macrophages (Fig. 3A) and CD4+ T lymphocytes (Fig.  3B) . Clone 3-3 also had limited replication in both cells types, whereas clone 3-4 isolated from the same PBMC sample replicated faster and to higher levels in macrophages (Fig. 3A) . The replication of this clone in CD4+ T lymphocytes was only marginally elevated (Fig. 3B) . Clone 4-3 had a pattern of replication similar to that of the biological clones from earlier time points, whereas clone 4-1 replicated efficiently to high levels in both macrophages (Fig. 3A) and CD4+ T lymphocytes (Fig. 3B) (43) . Preliminary experiments indicated that reverse transcription occurred much more slowly in macrophages than in PHA-stimulated PBMC (data not shown). Full-length HIV-1 DNA was not detected in macrophages until 24 to 48 h after infection (Fig. 4) , whereas signals were detected as early as 8 to 12 h after infection of PBMC. Increases in the PCR signal from 24 to 48 h could be blocked by the addition of AZT, confirming the presence of newly synthesized HIV-1 DNA. Forty-eight hours after infection, full-length HIV-1 DNA was detected in macrophages infected with each of the biological clones, indicating that these viruses were able to enter and reverse transcribe their genomes. However, 72 h after infection, the level of HIV-1 DNA had increased in macrophages infected with the rapidly replicating clones (3-4 and 4-1), whereas there was almost no change in the level of HIV-1 DNA detected in cells infected with the slowly replicating viruses (clones 2-5, 2-6, 3-3, and 4-3) (Fig. 4) .
This finding was confirmed by using a second pair of PCR primers which detect early products of reverse transcription. Twenty-four hours after infection, similar levels of HIV-1 DNA could be detected in macrophages infected with each of the biological clones, as judged from quantitation of DNA copy number ( Table 2 ). The amount of early HIV-1 DNA increased roughly twofold between 24 and 48 h and corresponded with the appearance of full-length HIV-1 DNA. However, 72 h after infection, the amount of early, reversetranscribed DNA had decreased by about 50% in cells infected with each of the slowly replicating clones, whereas approximately two-to fourfold-higher levels were detected in macrophages infected with the rapidly replicating clones. Decreases in the PCR signal seen with the slowly replicating viruses may reflect degradation of partially reverse transcribed viral DNA products, analogous to what has been observed in resting T lymphocytes (43) . Similar processes may also take place in cells infected with rapidly replicating viruses; however, these changes may be masked by more efficient initiation of secondary rounds of infection, which would effectively increase the levels of early reverse-transcribed DNA.
In separate experiments, macrophages were infected with equivalent amounts of either slowly (clones 2-5 and 2-6) or rapidly (clones 3-4 and 4-1) replicating biological clones. HIV-1 p24 antigen levels were measured in the culture super- with a standard curve generated by using DNA from 8E5 cells, which contain one integrated copy of HIV-1 per cell. The limits of sensitivity of the assay were .10 copies. Early DNA products of reverse transcription were measured by using PCR primers RC-1 and RC-2, which hybridize to the R/U5 region of the HIV-1 LTR. Complete or nearly complete HIV-1 DNA was measured by using primers M667 and M661, which recognize sequences in the LTR/gag region of the genome (43). NT, not tested. natants at regular intervals up to day 7, at which time the cells were harvested and analyzed by PCR for full-length HIV-1 DNA (Fig. 5) . The amount of p24 antigen measured in culture supernatants was roughly equivalent on day 3 after infection. However, by day 7, the p24 levels had increased rapidly in cultures infected with clones 3-4 and 4-1, while those infected with clones 2-5 and 2-6 showed only modest increases in p24 (Fig. SA) . PCR analysis of DNA extracted from the cells on day 7 revealed significantly higher levels of HIV-1 DNA in macrophages infected with the two rapidly replicating clones (Fig. SB) , indicating more efficient spread of these viruses in the culture.
Restricted replication in CD4+ T lymphocytes cannot be overcome by increasing inoculum. PCR was also used to evaluate entry and reverse transcription of selected biological clones in cultures enriched for CD4+ T lymphocytes. The cells were infected with equivalent inocula of clones 2-5, 2-6, 3-3, 3-4, 4-1, and 4-3. At designated times after infection, the cells were harvested and analyzed by PCR to determine the level of full-length HIV-1 DNA (Table 3) . Eight hours after infection, low levels of HIV-1 DNA could be detected in CD4+ T lymphocytes infected with each of the biological clones. By 24 h, the amount of HIV-1 DNA had increased among all clones, indicating that the viruses were able to mediate entry and reverse transcription. Increases in the PCR signal from 8 to 24 h could be inhibited by the addition of AZT, confirming the presence of newly synthesized viral DNA.
To test whether the poor replication of clones 2-5, 2-6, and 3-4 in CD4+ T lymphocytes was related to the quantity of inoculum, cells were infected with increasing amounts of each virus (102, 103, and 104 TCID5O). At high input virus concentrations (104 TCID50), clone 4-1 rapidly replicated to high levels (Fig. 6) . Decreasing the inoculum 10-and 100-fold resulted in a delay in p24 production (9); however, virus replication eventually reached comparably high levels. In contrast, replication of clones 2-5, 2-6, and 3-4 reached only low levels regardless of the inoculum (Fig. 6 ). Even when 100-fold more virus was added (104 TCID50 compared with 102 TCID50
for clone 4-1), replication of clones 2-5, 2-6, and 3-4 never reached the levels seen with clone 4-1. PCR analysis at 24 h indicated that the amount of virus entering the cells was directly related to the input inoculum (Fig. 7) . Increasing the inoculum by 10-and 100-fold resulted in an increase in the levels of HIV-1 DNA detected by PCR. (1, 12, 39) . In longitudinal studies, isolates from patients who progressed to AIDS had a higher rate of replication compared with isolates from individuals who remained asymptomatic (39) . Rapid CD4+ T-cell decline was associated with rapidly replicating, SI virus; however, in some cases, disease progression also occurred in patients with rapidly replicating, NSI virus (39) .
In the present study, we examined in detail the replicative properties of a series of virus isolates derived from a single patient soon after seroconversion and subsequently throughout the course of infection. We found a progressive increase in the ability of sequential isolates to replicate in primary cultures of PBMC, macrophages, and CD4+ lymphocytes. The most dramatic increase in replication kinetics occurred during the period when this patient was clinically asymptomatic, with normal CD4+ T-cell counts. We have since confirmed this finding in two additional patients with rapid disease progression and have consistently found only slowly replicating virus in one long-term survivor of HIV-1 infection (5a). These results support a growing body of evidence that HIV-1 replication is active during asymptomatic infection (11, 16, 26, 27) . Increased virus replication during this period may contribute to disease progression either directly by increasing the viral burden in tissues (11, 26) and peripheral blood (6, 16, 27) (17, 21, 33) . However, subtle differences in rates of entry and reverse transcription among our viral variants may escape detection in our assay system. It is as yet unclear which stage of replication is impaired in the slowly growing viruses. Increased replication of HIV-1 variants may reflect subtle differences in entry events or possibly more efficient processing and incorporation of the envelope glycoproteins into progeny virions. This effect would not be evident during the first round of replication in our assays, since the inoculum was adjusted for an equivalent number of infectious units. However, upon subsequent cycles of infection, this may increase the efficiency of CD4 binding and enhance virus-cell fusion and entry. Alternatively, rapidly replicating viruses may mediate cell-cell fusion more readily at a given level of surface-expressed envelope, leading to increased virus spread in culture (32) . Consistent with earlier studies by Tersmette et al. (38) , we found relatively inefficient spread of the slowly replicating viruses in culture despite early release of p24 into the supernatant (Fig. 5) . Further evaluation of sequential biological and molecular clones of HIV-1, which are likely to be highly related at the genetic level yet phenotypically distinct, should provide important clues as to the nature of the determinants which mediate these processes.
Changes in the in vitro replication rate of sequential virus isolates may reflect the emergence of variants with increased infectivity in vivo. Although recovery of rapidly replicating virus from HIV-1-infected patients is strongly associated with advanced disease, our results indicate that even during asymptomatic infection, the virus is subtly changing its biological properties. We have identified early changes in the replication rate of NSI viruses, particularly in macrophages, which precede the appearance of more virulent variants. Further longitudinal studies are now needed to determine whether these changes are significantly associated with subsequent disease progression.
